ovarian imaging and ovarian cancer
TRANSCRIPT
Ovarian Imaging and Ovarian Cancer
Patrick Yachimski—Harvard Medical School , Year- IIIGillian Lieberman, MD
January Patrick YachimskiGillian Lieberman,
2
Objectives
1) Introduction to ovarian cancer
2) Indications for ovarian imaging
3) Basic ovarian ultrasonography
4) Imaging in advanced disease
5) Imaging in screening and prognosis
Patrick YachimskiGillian Lieberman,
3
Statistics
• 3rd leading gynecologic cancer
• >50% of GYN cancer deaths
• 1995: 26,000 new U.S. Cases14,500 U.S. Deaths
Patrick YachimskiGillian Lieberman,
4
Risk factors
• Age (peak incidence 6th decade)
• Nulliparity
• North American or Northern European descent
• Personal history breast, endometrial, colon CA
• Family history ovarian CA
• Familial ovarian CA syndromes
Patrick YachimskiGillian Lieberman,
5
Lifetime risk of ovarian CA
• 1.4% for all women
• 5% for women with 1st-degree relative with ovarian cancer
Patrick YachimskiGillian Lieberman,
6
Ovarian CA subtypesType % of ovarian
neoplasms% of malignant ovarian neoplasms
examples
Surface epithelial stromal cell tumors
65-70 90 Serous, mucinous, endometrioid, clear cell, Brenner
Germ cell tumors 15-20 3-5 Teratoma, dysgerminoma, choriocarcinoma
Sex cord stromal tumors
5-10 2-3 Fibroma, granulosa-theca cell
Metastases to ovaries
5 5
Patrick YachimskiGillian Lieberman,
7
Presenting Signs/Sx
• Pelvic pain• Pelvic mass• Weight loss• Abdominal distention• Early satiety• Urinary symptoms
Patrick YachimskiGillian Lieberman,
8
Presenting Signs/Sx (cont.)
• Ovarian torsion presenting as acute abdomen
• Pelvic mass on vaginal exam in asymptomatic woman
Patrick YachimskiGillian Lieberman,
9
Ovarian Ultrasound
Transabdominal3.5-5.0 MHZ transducerfull bladder as acoustic window
Transvaginal (TVS)5.0-7.5 MHz transducerempty bladder!
Patrick YachimskiGillian Lieberman,
10
Indications for TVS (v. transabdominal)
• Uncertain transabdominal findings
• Better characterization of lesion
• Strong FH ovarian CA
• Retroverted, retroflexed uterus
Patrick YachimskiGillian Lieberman,
11
Who gets ultrasound?
1)Women with symptoms described earlier
2)Women with acute lower quadrant or periumbilical pain
3) Asymptomatic women with pelvic mass on vaginal exam
4) Women with familial ovarian CA syndrome, annual TVS until age 35
Patrick YachimskiGillian Lieberman,
12
Ultrasound terminology
• Echogenic or hyperechoic– This means grey or white!– Solid organs
• Echolucent or hypoechoic– This means black!– Fluid or cysts
Patrick YachimskiGillian Lieberman,
13
Normal ovary
BIDMC files
Patrick YachimskiGillian Lieberman,
14
Normal ovary• Ellipsoid• Central echogenic medulla• Homogeneous echotexture• Position variable• Anechoic follicles may be seen in
cortex
• Ovarian volume = (0.523 x length x width x height)• Normal volume:
– Premenopausal: 9.8 +/- 5.5 cc (upper limit nl as high as 22 cc)– Postmenopausal: 1.2-5.8 cc (>8.0 cc definitely abnormal)
BIDMC files
Patrick YachimskiGillian Lieberman,
15
Normal ovary• Ellipsoid• Central echogenic medulla• Homogeneous echotexture• Position variable• Anechoic follicles may be seen in
cortex
• Ovarian volume = (0.523 x length x width x height)• Normal volume:
– Premenopausal: 9.8 +/- 5.5 cc (upper limit nl as high as 22 cc)– Postmenopausal: 1.2-5.8 cc (>8.0 cc definitely abnormal)
• TVS detects 20-90% of postmenopausal ovaries
BIDMC files
Patrick YachimskiGillian Lieberman,
16
More normal ovaries
Patrick YachimskiGillian Lieberman,
17
Differential diagnosis of ovarian masses:
• Functional cyst• Follicular cyst• Corpus luteum cyst• Hemorrhagic cyst• Hematoma• Abscess
• Cystadenoma• Cystadenocarcinoma• Endometrioma• Ectopic pregnancy• Teratoma/Dermoid
Patrick YachimskiGillian Lieberman,
18
Let’s review some patients with adnexal pathology
Patrick YachimskiGillian Lieberman,
19
Patient A: right adnexa• History: 32 yo woman with 3 mo h/o right adnexal pain
BIDMC files
Patrick YachimskiGillian Lieberman,
20
Patient A: right adnexa
FILM FINDINGS There is a right adnexalmass which is:
• Anechoic• Has well-defined, thin walls• Shows posterior acoustic
enhancement
Diagnosis:Classic functional ovarian cyst
*Functional cysts are the most common cause of ovarian enlargement in young women
BIDMC files
Patrick YachimskiGillian Lieberman,
21
Patient A: left adnexa
BIDMC files
Patrick YachimskiGillian Lieberman,
22
Patient A: left adnexa
FILM FINDINGS
• Heterogeneuous leftovarian mass withthrough transmission
• Characteristic cystic masswith echogenic mural nodule(“dermoid plug”)
Diagnosis:Left ovarian teratoma (a.k.a. ovarian dermoid)
Patrick YachimskiGillian Lieberman,
23
Patient B: right ovaryHistory: 34 yo woman with 1 wk h/o RLQ pain
BIDMC files
Patrick YachimskiGillian Lieberman,
24
Patient B: right ovary
FILM FINDINGS
• Right ovarian mass; low level internal echoes with enhanced through transmission
Diagnosis:Endometrioma
Patrick YachimskiGillian Lieberman,
25
Patient C: left ovaryHistory: 19 yo woman with RLQ pain, dyspareunia
BIDMC files
Patrick YachimskiGillian Lieberman,
26
Patient C: left ovary
BIDMC files
FILM FINDINGS
Left adnexal mass featuring:
•Hyperechoic (“lace- like” pattern)
•Smooth posterior wall
•Posterior acoustic enhancement
Diagnosis:
Hemorrhagic cyst
Hemorrhagic cyst may show septations and reticular pattern as clot hemolyzes, or may mimic a solid mass
Patrick YachimskiGillian Lieberman,
27
Patient D: left adnexaHistory: 86 yo woman with recent onset fatigue, weight loss, early satiety
BIDMC files
FILM FINDING: there is an irregular cystic lesion of the left ovary
Patrick YachimskiGillian Lieberman,
28
Ultrasound findings suggestive of malignancy in cystic lesions of the ovary:
• Irregular walls
• Thick, irregular septations
• Mural nodules
• Solid echogenic elements
Patrick YachimskiGillian Lieberman,
29
Patient D’s ultrasound is consistent with that of ovarian neoplasm:
Irregular walls
Mural nodules
Patrick YachimskiGillian Lieberman,
30
Complex cysts may be benign or malignant.
So, how do we tell the difference?
• Pre-test probability– It is uncommon for younger women to have some
forms of ovarian neoplasms—but not impossible! – So, we can not categorically r/o malignancy based on
Hx and Sx alone.
• Repeat TVS imaging?
Patrick YachimskiGillian Lieberman,
31
Recommendations:
• If unilocular cyst:– Repeat TVS in 4-6 wks
to demonstrate resolution
– Premenopausal woman with simple cystic adnexal mass <6-10 cm diameter, 70% will resolve spontaneously
• Simple, unilateral cyst, asymptomatic, nl gyn exam, nl Pap, nl CA-125:– <3 cm, follow with TVS– >3 cm, laparoscopy
• Laparotomy indicated:– Cyst >5 cm– Cyst with internal
septations and/or solid nodules
– Symptomatic– High CA-125
Premenopausal Postmenopausal
Patrick YachimskiGillian Lieberman,
32
A suspicious ovarian cyst should NEVER be percutaneously drained or aspirated!
Patrick YachimskiGillian Lieberman,
33
Call gyn onc!
Patrick YachimskiGillian Lieberman,
34
FIGO staging of ovarian CA:• Stage I—limited to ovaries
– Ia—one ovary, no ascites with + cytology, no tumor on external surface, capsule intact
– Ib—both ovaries, no ascites with + cytology, no tumor on external surface, capsule intact
– Ic—tumor stage Ib or Ic but with ascites, or + peritoneal washings, or capsule rupture
• Stage II—pelvic extension– IIa—uterus and/or fallopian tubes– IIb—other pelvic tissues– IIc—tumor stage IIa or IIb but with ascites, + peritoneal washings, or capsule
rupture
Patrick YachimskiGillian Lieberman,
35
FIGO staging (cont.):• Stage III—peritoneal mets/superficial liver mets/retroperitoneal nodes
– IIIa—limited to pelvis, negative nodes, microscopic seeding of peritoneum
– IIIb—peritoneal implants no larger than 2 cm diameter– IIIc—peritoneal implants >2 cm diameter, or + retroperitoneal or inguinal
nodes• Stage IV—pelvic extension
– Distant mets (including pleural effusion, intrahepatic mets)
Patrick YachimskiGillian Lieberman,
36
Staging:
• Ovarian CA is staged surgically
• 70% of women, when diagnosed, are advanced stage (stage III or IV)
Patrick YachimskiGillian Lieberman,
37
Early stage disease:
• Stage Ia and Ib generally do not require chemoRx
• However, rupture or “spillage” of early stage tumor can theoretically advance tumor stage
• Implantation mets at laparoscopy trochar puncture sites (micrometastases seeding scar tissue)
Patrick YachimskiGillian Lieberman,
38
5-year survival
• Stage I 73%
• Stage II 46%
• Stage III 17%
• Stage IV 5%
Patrick YachimskiGillian Lieberman,
39
Patient E: plain abdominal film
• History: 68 yo woman with several week h/o abdominal pain and constipation
BIDMC files
Patrick YachimskiGillian Lieberman,
40
Patient E
FILM FINDINGS: (SUBTLE!)
1) Probable ascites (“ground glass” abdomen)
2) Suggestion of pelvic soft tissue density
3) No evidence bowel obstruction
BIDMC files
Patrick YachimskiGillian Lieberman,
41
DDx pelvic soft tissue mass:
• Abscess• Distended bladder• Distended/filled bowel
loop• Feces in rectosigmoid• Hematoma • Ovarian cyst or neoplasm• Pregnancy• Fibroids, hydatid mole,
other uterine neoplasm
• Anterior sacral meningocele
• Bone tumor• Extraperitoneal neoplasm• Hydatid cyst• Pelvic kidney• Pelvic lipomatosis
Commo Uncommon
Source: Felson’s Gamut
Patrick YachimskiGillian Lieberman,
42
Abdominal CT of Patient E confirmed….
BIDMC files
Patrick YachimskiGillian Lieberman,
43
Abdominal CT of Patient E confirmed….free fluid
BIDMC files
Patrick YachimskiGillian Lieberman,
44
But what’s this?
BIDMC files
Patrick YachimskiGillian Lieberman,
45
And this? (from a lower axial section)
BIDMC files
Patrick YachimskiGillian Lieberman,
46
And this? (from a lower axial section)
BIDMC files
Answer:
Peritoneal implants from metastatic disease
Patrick YachimskiGillian Lieberman,
47
Pelvic CT of the same patient:
BIDMC files
Patrick YachimskiGillian Lieberman,
48
Pelvic CT of the same patient:
FILM FINDINGS:
6x7 cm heterogeneous mass in right hemipelvis
BIDMC files
Patrick YachimskiGillian Lieberman,
49
Pelvic section from Patient E:
BIDMC files
Patrick YachimskiGillian Lieberman,
50
Pelvic section from patient E:
FILM FINDINGS:
Diffuse “omental caking”:
Soft tissue nodules (mets) embedded in omental fat
Diagnosis:Metastatic right ovarian cancer with omental cake, multiple peritoneal implants, and ascites
BIDMC files
Patrick YachimskiGillian Lieberman,
51
Common sites of metastasis in Ovarian Cancer:
• Stomach• Large bowel• Small bowel• Pelvic ureter• Liver
• Pelvic nodes• Para-aortic nodes• Peritoneum
– Right subphrenic space– Greater omentum– Rectouterine pouch (of
Douglas)
Patrick YachimskiGillian Lieberman,
52
Different patients with metastatic disease:
Courtesy Jeong et al, , “Imaging Evaluation of Ovarian Masses”, Radiographics, 2000;20:1445-1470, at http://radiographics.rsnajnls.org
MR demonstrating peritoneal enhancement in patient with metastatic serous tumor
Ct showing calcified implants in Stage IIIa papillary ovarian CA
Patient F Patient G
Patrick YachimskiGillian Lieberman,
53
Staging laparotomy
• TAHBSO
• Omentectomy
• Peritoneal biopsy
• Lymph node biopsy
Patrick YachimskiGillian Lieberman,
54
Screening to detect early disease?
• Based on incidence, screening test with 99% specificity and 100% sensitivity would yield 1 in 21 women with disease (PPV 4.8%)
• 5-10% of women with suspicious adnexal mass will undergo surgery, and of these masses, only 13-21% will prove malignant
• Doppler sonography?– Malignant masses will have high diastolic flow
Patrick YachimskiGillian Lieberman,
55
TVS screening in asymptomatic women: a study from Japan (Sato et. al., 2000)
• Primary screening of asymptomatic women >30 yo, who also underwent annual screening for cervical CA
• 10 year study
• 183,034 women underwent primary screening– 4 TVS views– Secondary screening including full TVS, tumor markers
• 320 women underwent laparotomy– 22 women diagnosed with ovarian CA
Patrick YachimskiGillian Lieberman,
56
TVS screening in asymptomatic women: a study from Japan (Sato et. al., 2000)
• 17/22 had stage I disease (77%)
• 2/22 had stage II disease (9%)
• 2/22 had stage III disease (9%)
• 1/22 had stage IV disease (5%)
Patrick YachimskiGillian Lieberman,
57
TVS screening in asymptomatic women: a study from Japan (Sato et. al., 2000)
I 29.7% 58.8%
II 13.5% 9.4%
III 43.3% 22.4%
IV 13.5% 9.4%
Stage Pre-screening Post-screening
Patrick YachimskiGillian Lieberman,
58
TVS screening in asymptomatic women: a study from Japan (Sato et. al., 2000)
Summary:
• screening TVS in asymptomatic women led to earlier stage diagnosis when compared with controls
• Detection of early stage disease may lead to an improved 5-year survival
Patrick YachimskiGillian Lieberman,
59
CT in ovarian CA:
• Current uses of CT– Assess disease extent pre-op– Substitute for 2nd-look laparotomy
• High false negative rate for identifying residual disease post-chemo
Patrick YachimskiGillian Lieberman, MD
60
CT as prognostic test in women with known disease?
• Amount of residual disease post surgical reduction and prior to chemo is important prognostic indicator (Goldie-Coldman hypothesis)
• How often does optimal surgical reduction occur?
Patrick YachimskiGillian Lieberman, MD
61
Bristow et al., “A model for predicting surgical outcome in patients with advanced ovarian
carcinoma using computed tomography” (2000)
• Goal: predict outcome of primary cytoreductive surgery
• 41 patients (MGH and JHU)
• Optimal result: <=1 cm maximal diameter residual disease
• 25 radiographic features as potential indicators of surgical outcome
• Results:– 3 patients with stage IIIb disease– 29 patients with stage IIIc disease– 9 patients with Stage IV disease
Patrick YachimskiGillian Lieberman, MD
62
Bristow et al., “A model for predicting surgical outcome in patients with advanced ovarian
carcinoma using computed tomography” (2000)
• CT features most strongly associated with surgical outcome:– Peritoneal thickening– Peritoneal implants >=2 cm – Bowel mesentery involvement >=2 cm– Suprarenal paraaortic nodes >=1 cm– Omental extension– Pelvic sidewall involvement/hydroureter
Patrick YachimskiGillian Lieberman, MD
63
Bristow et al., “A model for predicting surgical outcome in patients with advanced ovarian
carcinoma using computed tomography” (2000)
• Features assigned point value to generate Predictive Index score
• 9 different gyn onc surgeons
• Unnecessary exploration (NPV)—women who undergo laparoscopy and are in retrospect found to be poor surgical candidates by virtue of their tumor burden
• Inappropriate unexploration (specificity)—women who do not undergo laparoscopy, and who in retrospect are found to be appropriate surgical candidates by virtue of their tumor burden
Patrick YachimskiGillian Lieberman, MD
64
Bristow et al., “A model for predicting surgical outcome in patients with advanced ovarian
carcinoma using computed tomography” (2000)
Predicitive Index Score Unnecessarily Explored (%)
Inappropriately Unexplored (%)
>=1 0 50.0>=2 0 45.0>=3 0 25.0>=4 0 15.0>=5 6.0 15.0>=6 10.6 15.0>=7 13.6 5.0>=8 26.9 5.0>=9 31.0 0>=10 37.5 0
Patrick YachimskiGillian Lieberman, MD
65
Bristow et al., “A model for predicting surgical outcome in patients with advanced ovarian
carcinoma using computed tomography” (2000)
Summary:
The ability of CT to quantify tumor burden may help to
1) identify women who will most benefit from laparoscopy
2) spare women with high tumor burden from unnecessary surgical morbidity
Patrick YachimskiGillian Lieberman, MD
66
Summary:We have covered:
• Introduction to ovarian cancer
• Indications for ovarian imaging
• Basic ovarian ultrasonography
• Imaging in advanced disease
• Imaging in screening and prognosis
Patrick YachimskiGillian Lieberman, MD
67
References:• Ascher et al, “Diagnostic Imaging Techniques in Gynecologic Oncology, in Hoskins et al, Principles
and Practice of Gynecologic Oncology (2nd ed.), Lippincott-Raven, 1997• Bristow et al, “A Model for Predicting Surgical Outcome in Patients with Advanced Ovarian
Carcinoma Using Computed Tomography”, Cancer October 1, 2000, Vol.89, No.7, pp.1532-1540• Cotran et al, Robbins Pathologic Basis of Disease, W.B. Saunders Company, 1999• Felson, Gamut• Jeong et al, “Imaging Evaluation of Ovarian Masses”, Radiographics. 2000;20:1445-1470 [cited
http://radiographics.rsnajnls.org/ 2001 January 17]• Kupesic et al, “Contrast-Enhanced, Three-Dimensional Power Doppler Sonography for
Differentiation of Adnexal Masses”, Obstetrics & Gynecology, Vol.96, No.3, September 2000, pp. 452-458
• Morrow and Curtin, Synopsis of Gynecologic Oncology (5th ed.), Churchill Livingstone, 1998• Ovarian Cancer: Screening, Treatment and Followup. NIH Consensus Statement Online 1994 April
5-7; [cited 2001 January 17] 12(3): 1-30• Salem, “The Uterus and Adnexa”, in Rumack et al, Diagnostic Ultrasound (2nd ed.), Mosby-Year
Book, 1998• Sato et al, “Usefulness of Mass Screening for Ovarian Carcinoma Using Transvaginal
Ultrasonography”, Cancer August 1, 2000, Vol.89, No.3, pp. 582-588
Patrick YachimskiGillian Lieberman, MD
68
• David Lin, M.D.• Beverlee Turner for her support and
PowerPoint expertise• Larry Barbaras and Ben Crandall our
WebMasters
Patrick YachimskiGillian Lieberman, MD